5.3.3.5: cholestenol DELTA-isomerase
This is an abbreviated version!
For detailed information about cholestenol DELTA-isomerase, go to the full flat file.
Word Map on EC 5.3.3.5
-
5.3.3.5
-
ebp
-
x-linked
-
chondrodysplasia
-
punctata
-
stipple
-
sigma1
-
epiphyseal
-
x-inactivation
-
8-dehydrocholesterol
-
nsdhl
- 5.3.3.5
- ebp
-
x-linked
-
chondrodysplasia
- punctata
-
stipple
-
sigma1
-
epiphyseal
-
x-inactivation
- 8-dehydrocholesterol
- nsdhl
Reaction
Synonyms
3beta-hydroxysteroid DELTA8,7-sterol isomerase, 3beta-hydroxysteroid DELTA8-DELTA7 isomerase, 8,7SI, C-8,7 sterol isomerase, Cholestenol delta-isomerase, D8-D7 sterol isomerase, D8D7I, DELTA8,7-isomerase, DELTA8,7-sterol isomerase, DELTA8-Cholestenol-DELTA7-cholestenol isomerase, DELTA8-DELTA7 isomerase, Delta8-delta7 sterol isomerase, DELTA8-SI, EBP, Emopamil binding protein, emopamil-binding protein, ERG2p, HSI, Isomerase, cholestenol DELTA-, SI, SI1, sterol 8,7-isomerase, sterol DELTA8 isomerase
ECTree
Advanced search results
Natural Substrates Products
Natural Substrates Products on EC 5.3.3.5 - cholestenol DELTA-isomerase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
REACTION DIAGRAM
5alpha-cholest-7-en-3beta-ol
?
enzyme of the cholesterol biosynthetic pathway, mutations are associated with Conradi-Huenermann syndrome. The enzyme may be involved in liver function, since the mRNA is only detected in hepatocytes not in connective tissue or blood vessels. The expression of the SI gene is regulated transcriptionally in vitro and in vivo by widely known regulatory agents ranging from tamoxifen, an oestrogen receptor antagonist and SI-specific inhibitor, to cholesterol-lowering drugs
-
?